Overview of Dr. Goorha
Dr. Salil Goorha, MD, based in Memphis, TN, specializes in Oncology with a subspeciality in Hematologic Oncology. He completed his education at the University of Tennessee and the University of Utah Health, gaining experience in immunotherapy, genomics, stem cell transplantation, and hematologic oncology. He has multiple notable publications in various esteemed journals, contributing significantly to research in his field. Dr. Goorha has been the Principal Investigator in a number of clinical trials and was honored with the Young Investigator Award from the American Society Clinical Oncology in 2010.
Office
6027 Walnut Grove Rd
Suite 206
Memphis, TN 38120
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2006 - 2008
University of Utah HealthResidency, Internal Medicine, 2000 - 2003
University of Tennessee Health Science Center College of MedicineClass of 2000
Certifications & Licensure
AK State Medical License 2012 - Present
MS State Medical License 2009 - 2025
TN State Medical License 2003 - 2025
AR State Medical License 2010 - 2022
UT State Medical License 2001 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award American Society Clinical Oncology, 2010
Clinical Trials
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies Start of enrollment: 2009 Sep 01
- The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies Start of enrollment: 2020 Nov 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 7 citationsAllogeneic CD34selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infection.Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha
Pediatric Blood & Cancer. 2023-03-01 - 9 citationsRisk Factors for Mortality and Progression to Severe COVID-19 Disease in the Southeast United States (US): A Report from the SEUS Study Group.Athena L V Hobbs, Nicholas A Turner, Imad Omer, Morgan Walker, Ronald M Beaulieu
Infection Control and Hospital Epidemiology. 2021-01-11 - 9 citationsEvaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction TherapyNathan D. Seligson, Athena L V Hobbs, Joanna M Leonard, Elizabeth L Mills, Amy G Evans
The Annals of Pharmacotherapy. 2018-05-01
Other Languages
- Hindi, Urdu
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
Anthem Blue Preferred Plus POS
Anthem Blue Preferred Select
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Tennessee Network 5
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPOCoventry Carelink Health Plans PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
Health Alliance PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Humana/ChoiceCare+ Network PPO
Multiplan PHCS PPO
Multiplan PPO
Qualchoice PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
